REGISTERED NUMBER: |
Unaudited Financial Statements for the Year Ended 30th June 2024 |
for |
Revalidaid (UK) Ltd |
REGISTERED NUMBER: |
Unaudited Financial Statements for the Year Ended 30th June 2024 |
for |
Revalidaid (UK) Ltd |
Revalidaid (UK) Ltd (Registered number: 08586448) |
Contents of the Financial Statements |
for the Year Ended 30th June 2024 |
Page |
Balance Sheet | 1 |
Notes to the Financial Statements | 2 |
Revalidaid (UK) Ltd (Registered number: 08586448) |
Balance Sheet |
30th June 2024 |
30.6.24 | 30.6.23 |
Notes | £ | £ |
CURRENT ASSETS |
Cash at bank |
CREDITORS |
Amounts falling due within one year | 4 |
NET CURRENT LIABILITIES | ( |
) | ( |
) |
TOTAL ASSETS LESS CURRENT LIABILITIES |
( |
) |
( |
) |
CAPITAL AND RESERVES |
Called up share capital | 5 |
Retained earnings | ( |
) | ( |
) |
SHAREHOLDERS' FUNDS | ( |
) | ( |
) |
The directors acknowledge their responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
The financial statements were approved by the Board of Directors and authorised for issue on |
Revalidaid (UK) Ltd (Registered number: 08586448) |
Notes to the Financial Statements |
for the Year Ended 30th June 2024 |
1. | COMPANY INFORMATION |
Revalidaid (UK) Ltd is a |
Registered number: |
Registered office: |
The presentation currency of the financial statements is the Pound Sterling (£). |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
Taxation |
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
Current or deferred taxation assets and liabilities are not discounted. |
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
Going concern |
At the time of approving the financial statements, the director has confirmed that they will continue to support the company and ensure it has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements. |
3. | EMPLOYEES AND DIRECTORS |
The average number of employees during the year was |
Revalidaid (UK) Ltd (Registered number: 08586448) |
Notes to the Financial Statements - continued |
for the Year Ended 30th June 2024 |
4. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
30.6.24 | 30.6.23 |
£ | £ |
Credit card account |
Other creditors |
Directors' current accounts | 976 | 664 |
Accrued expenses |
5. | CALLED UP SHARE CAPITAL |
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 30.6.24 | 30.6.23 |
value: | £ | £ |
Ordinary A | £1 | 60 | 60 |
Ordinary B | £1 | 40 | 40 |
100 | 100 |
The A Shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company. |
The B Shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company. |
The A and B Shares rank pari passu in respect of dividend and capital distribution rights |
6. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES |
The following advances and credits to a director subsisted during the years ended 30th June 2024 and 30th June 2023: |
30.6.24 | 30.6.23 |
£ | £ |
Balance outstanding at start of year | ( |
) |
Amounts advanced |
Amounts repaid | ( |
) | ( |
) |
Amounts written off | - | - |
Amounts waived | - | - |
Balance outstanding at end of year | ( |
) | ( |
) |
The loan is repayable on demand and no interest was charged during the year. |
7. | RELATED PARTY DISCLOSURES |
Included in Other creditors is a balance of £4,275 due to Shabeer Medic Limited, a company in which Dr Kolakkat has a controlling interest. All transactions were made on an arms length basis |
8. | ULTIMATE CONTROLLING PARTY |
The ultimate controlling party is Dr Kolakkat by virtue of holding 100% of the voting share capital. |